Bibliotecas PUC-SP - Busca Integrada

Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective

Por Alberto Puccini, Andreas Seeber, Martin D. Berger
Publicado no Cancers (2022-10-01)

Editorial: New therapeutic approaches in microsatellite stable colorectal cancer patients

Por Michela Bartolini, Michela Bartolini, Andreas Seeber, Alberto Puccini
Publicado no Frontiers in Oncology (2023-07-01)

Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives

Por Kai Zimmer, Florian Kocher, Alberto Puccini, Andreas Seeber
Publicado no Frontiers in Oncology (2021-10-01)

Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies

Por Alberto Puccini, Maria Laura Iaia, Mohamed E Salem
Publicado no Journal for ImmunoTherapy of Cancer (2020-05-01)

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives

Por Annalice Gandini, Silvia Puglisi, Chiara Pirrone, Valentino Martelli, Fabio Catalano, Simone Nardin, Andreas Seeber, Alberto Puccini, Alberto Puccini, Stefania Sciallero
Publicado no Frontiers in Oncology (2023-05-01)

Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions

Por Francesca Battaglin, Madiha Naseem, Alberto Puccini, Heinz-Josef Lenz
Publicado no Cancer Cell International (2018-07-01)

Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping...

Por Linda Battistuzzi, Eva Blondeaux, Alberto Puccini, Luca Boni, Federica Grillo, Lucia Trevisan, Liliana Varesco, Maria Stefania Sciallero
Publicado no JMIR Research Protocols (2025-06-01)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer

Por Fabio Catalano, Roberto Borea, Silvia Puglisi, Andrea Boutros, Annalice Gandini, Malvina Cremante, Valentino Martelli, Stefania Sciallero, Alberto Puccini
Publicado no Cancers (2022-03-01)

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients

Por Bruna Dalmasso, Alberto Puccini, Fabio Catalano, Roberto Borea, Maria Laura Iaia, William Bruno, Giuseppe Fornarini, Stefania Sciallero, Sara Elena Rebuzzi, Paola Ghiorzo
Publicado no International Journal of Molecular Sciences (2022-04-01)

Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

Por Valentina Daprà, Marco Airoldi, Michela Bartolini, Roberta Fazio, Giuseppe Mondello, Maria Chiara Tronconi, Maria Giuseppina Prete, Giuseppe D’Agostino, Caterina Foppa, Antonino Spinelli, Alberto Puccini, Armando Santoro
Publicado no International Journal of Molecular Sciences (2023-07-01)

Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients

Por Madiha Naseem, Shu Cao, Dongyun Yang, Joshua Millstein, Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, Chiara Cremolini, Ryuma Tokunaga, Francesca Battaglin, Shivani Soni, Martin D. Berger, Afsaneh Barzi, Wu Zhang, Alfredo Falcone, Volker Heinemann, Heinz-Josef Lenz
Publicado no Scientific Reports (2021-06-01)

<i>WRN</i>-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype

Por Kai Zimmer, Alberto Puccini, Joanne Xiu, Yasmine Baca, Gilbert Spizzo, Heinz-Josef Lenz, Francesca Battaglin, Richard M. Goldberg, Axel Grothey, Anthony F. Shields, Mohamed E. Salem, John L. Marshall, W. Michael Korn, Dominik Wolf, Florian Kocher, Andreas Seeber
Publicado no Cancers (2020-05-01)

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients

Por Alberto Puccini, Marta Ponzano, Bruna Dalmasso, Irene Vanni, Annalice Gandini, Silvia Puglisi, Roberto Borea, Malvina Cremante, William Bruno, Virginia Andreotti, Eleonora Allavena, Valentino Martelli, Fabio Catalano, Massimiliano Grassi, Maria Laura Iaia, Chiara Pirrone, Alessandro Pastorino, Giuseppe Fornarini, Stefania Sciallero, Paola Ghiorzo, Lorenza Pastorino
Publicado no Cancers (2022-09-01)

Prognostic impact of depth of response and early tumour shrinkage in patients with -mutated metastatic colorectal cancer treated with targeted therapy

Por Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti, Lisa Salvatore, Filippo Pietrantonio, Sara Lonardi, Maria Bensi, Filippo Ghelardi, Maria Alessandra Calegari, Rossana Intini, Alessandro Minelli, Francesco Giulio Sullo, Chiara Boccaccio, Ada Taravella, Alberto Puccini, Daniele Lavacchi, Laura Noto, Massimiliano Salati, Mario Scartozzi, Chiara Cremolini
Publicado no Therapeutic Advances in Medical Oncology (2025-01-01)

Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual...

Por Vincenzo Nasca, Francesca Bergamo, Luisa Foltran, Lorenzo Antonuzzo, Katia Bencardino, Emanuela Dell’Aquila, Salvatore Corallo, Andrea Spallanzani, Oronzo Brunetti, Daniele Spada, Stefano Tamberi, Chiara Alessandra Cella, Antonio Avallone, Lorenzo Fornaro, Samantha Di Donato, Antonia Strippoli, Alberto Puccini, Emiliano Tamburini, Federica Palermo, Federica Morano, Filippo Pietrantonio, Alessandra Raimondi
Publicado no BMC Cancer (2025-04-01)

Molecular profile of BRCA-mutated biliary tract cancers

Por Michael Hall, Arno Amann, Joanne Xiu, Alberto Puccini, Francesca Battaglin, Heinz-Josef Lenz, Mohamed E Salem, Gilbert Spizzo, Richard M Goldberg, Axel Grothey, Anthony F Shields, Sukeshi Patel Arora, Yasmine Baca, Wafik S El-Deiry, Philip A Philip, Madiha Nassem, John L Marshall, Florian Kocher, Dominik Wolf, W Michael Korn, Andreas Seeber, Moh’d Khushman
Publicado no ESMO Open (2020-05-01)

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

Por Alberto Puccini, Andreas Seeber, Joanne Xiu, Richard M. Goldberg, Davide Soldato, Axel Grothey, Anthony F. Shields, Mohamed E. Salem, Francesca Battaglin, Martin D. Berger, Wafik S. El-Deiry, Ryuma Tokunaga, Madiha Naseem, Wu Zhang, Sukeshi Patel Arora, Moh’d M. Khushman, Michael J. Hall, Philip A. Philip, John L. Marshall, W. Michael Korn, Heinz-Josef Lenz
Publicado no npj Precision Oncology (2021-10-01)

Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM)

Por Oriana Ciani, Carla Ida Ripamonti, Fabio Efficace, Giuseppe Viscardi, Francesco De Lorenzo, Massimo Di Maio, Lara Gitto, Elisabetta Iannelli, Francesco Perrone, Ethan Basch, Alessandra Raimondi, Antonella Brunello, Carmine Pinto, Alberto Puccini, Silvana Quaglini, Evaristo Maiello, Martina Pagliuca, Saverio Cinieri, Gianmauro Numico, Paolo Bossi, Patrizia Popoli, Tiziana Latiano, Laura Marandino, Francesco Longo, Alberto Servetto, Angela Piattelli, Giordano Domenico Beretta, Davide Petruzzelli, Marco Zibellini, Laura Locati, Gualberto Gussoni, Gianluca Mignone, Pricivel M Carrera
Publicado no BMJ Oncology (2025-06-01)

PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

Por Kai Zimmer, Florian Kocher, Gerold Untergasser, Brigitte Kircher, Arno Amann, Yasmine Baca, Joanne Xiu, W. Micheal Korn, Martin D. Berger, Heinz-Josef Lenz, Alberto Puccini, Elisa Fontana, Anthony F. Shields, John L. Marshall, Michael Hall, Wafik S. El-Deiry, David Hsiehchen, Teresa Macarulla, Josep Tabernero, Renate Pichler, Moh’d Khushman, Upender Manne, Emil Lou, Dominik Wolf, Viktorija Sokolova, Simon Schnaiter, Alain G. Zeimet, Pat Gulhati, Gerlig Widmann, Andreas Seeber
Publicado no npj Precision Oncology (2023-07-01)